Suppr超能文献

[以脱镁叶绿酸-a作为光敏剂的光动力疗法评估]

[Evaluation of photodynamic therapy using pheophorbide-a as a photosensitizer].

作者信息

Yamashita Y, Moriyasu F, Tamada T, Kawasaki T, Ono S, Kimura T, Kajimura K, Someda H, Hamato N, Uchino H

机构信息

1st Department of Internal Medicine, Faculty of Medicine, Kyoto University.

出版信息

Nihon Gan Chiryo Gakkai Shi. 1990 Jun 20;25(6):1123-8.

PMID:2168925
Abstract

Intra-tumoral concentrations of pheophorbide-a, a new photosensitizer, were measured by high-performance liquid chromatography after administration of pheophorbide-a to nude mice (BALB/c-nu) that had been implanted with human hepatocellular carcinoma. The results were as follows: 1) 0.009 +/- 0.007 microgram/g tissue in 1 mg/kg body p.o. administration group, 2) 0.22 +/- 0.06 microgram/g tissue in 250 mg/kg body p.o. administration group, 3) 0.85 +/- 0.14 microgram/g tissue in 5 mg/kg body intra-peritoneal administration group, 4) 3.42 +/- 2.84 microgram/g tissue in not-injected side, and 116 +/- 24 microgram/g tissue in injected side of 200 micrograms intra-tumoral administration group. Tumors in each group were irradiated using an Nd:YAG laser (Q-switch; mean power 0.5 W, duration 10 min.). Areas of tumor necrosis were larger than in the control group only in the intra-tumoral administration group. These results suggest that no photodynamic reaction occurs if the intra-tumoral pheophorbide-a concentration is less than 0.85 microgram/g tissue.

摘要

给接种了人肝细胞癌的裸鼠(BALB/c-nu)注射脱镁叶绿酸-a后,通过高效液相色谱法测量肿瘤内新型光敏剂脱镁叶绿酸-a的浓度。结果如下:1)口服给药剂量为1mg/kg体重组,肿瘤内浓度为0.009±0.007微克/克组织;2)口服给药剂量为250mg/kg体重组,肿瘤内浓度为0.22±0.06微克/克组织;3)腹腔注射给药剂量为5mg/kg体重组,肿瘤内浓度为0.85±0.14微克/克组织;4)瘤内注射200微克组,未注射侧肿瘤内浓度为3.42±2.84微克/克组织,注射侧为116±24微克/克组织。每组肿瘤均使用Nd:YAG激光(调Q;平均功率0.5W,持续时间10分钟)照射。仅瘤内注射给药组肿瘤坏死面积大于对照组。这些结果表明,如果肿瘤内脱镁叶绿酸-a浓度低于0.85微克/克组织,则不会发生光动力反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验